IL92030A - Pharmaceutical preparations containing FPC peptides or analogues and their history - Google Patents

Pharmaceutical preparations containing FPC peptides or analogues and their history

Info

Publication number
IL92030A
IL92030A IL9203089A IL9203089A IL92030A IL 92030 A IL92030 A IL 92030A IL 9203089 A IL9203089 A IL 9203089A IL 9203089 A IL9203089 A IL 9203089A IL 92030 A IL92030 A IL 92030A
Authority
IL
Israel
Prior art keywords
amino acid
peptide
basic
cpf
hydrophilic amino
Prior art date
Application number
IL9203089A
Other languages
English (en)
Hebrew (he)
Original Assignee
Magainin Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Sciences Inc filed Critical Magainin Sciences Inc
Publication of IL92030A publication Critical patent/IL92030A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL9203089A 1988-10-21 1989-10-17 Pharmaceutical preparations containing FPC peptides or analogues and their history IL92030A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26086188A 1988-10-21 1988-10-21
US36268989A 1989-06-07 1989-06-07

Publications (1)

Publication Number Publication Date
IL92030A true IL92030A (en) 1994-05-30

Family

ID=26948228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9203089A IL92030A (en) 1988-10-21 1989-10-17 Pharmaceutical preparations containing FPC peptides or analogues and their history

Country Status (10)

Country Link
EP (1) EP0440688B1 (ko)
JP (1) JPH04502901A (ko)
KR (1) KR900701299A (ko)
CN (1) CN1043874A (ko)
AT (1) ATE111742T1 (ko)
AU (1) AU4410989A (ko)
CA (1) CA2001008A1 (ko)
DE (1) DE68918453T2 (ko)
IL (1) IL92030A (ko)
WO (1) WO1990004407A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
EP0579763A4 (en) * 1991-04-08 1994-12-21 Magainin Pharma NOVEL PEPTIDE COMPOSITIONS AND USES.
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
GB9501300D0 (en) * 1995-01-24 1995-03-15 Boughton Brian J Peptides which inhibit viruses
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
JP3860838B2 (ja) 1995-08-23 2006-12-20 ユニバーシティー オブ ブリティッシュ コロンビア 抗微生物性陽イオン性ペプチドおよびそのスクリーニング方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use

Also Published As

Publication number Publication date
EP0440688A4 (en) 1992-07-08
CA2001008A1 (en) 1990-04-21
ATE111742T1 (de) 1994-10-15
KR900701299A (ko) 1990-12-01
EP0440688B1 (en) 1994-09-21
AU4410989A (en) 1990-05-14
CN1043874A (zh) 1990-07-18
DE68918453D1 (de) 1994-10-27
WO1990004407A1 (en) 1990-05-03
DE68918453T2 (de) 1995-02-23
EP0440688A1 (en) 1991-08-14
JPH04502901A (ja) 1992-05-28

Similar Documents

Publication Publication Date Title
US5221664A (en) Composition and treatment with biologically active peptides and toxic cations
AU665030B2 (en) Biologically active amphiphilic peptide compositions and uses therefor
US5073542A (en) CPF peptide compositions and their use in inhibiting growth of target cells or a virus
AU674525B2 (en) Biologically active peptides having N-terminal substitutions
US5235038A (en) Deletion and substitution analogues of melittin peptide
US5225399A (en) Antimicrobial amphiphilic peptides
AU654714B2 (en) Novel peptide compositions and uses therefor
US5217956A (en) Composition and treatment with biologically active peptides and certain anions
EP0440688B1 (en) Cpf peptide compositions and uses
KR20170053877A (ko) 벼메뚜기에서 유래한 항균 펩타이드 옥시야신-2 및 그의 조성물
EP0416035A1 (en) AMPHIPHILE PEPTIDES AND THEIR USE.
KR20170053879A (ko) 벼메뚜기에서 유래한 항균 펩타이드 옥시야신-1 및 그의 조성물
AU641129B2 (en) Composition and treatment with biologically active peptides and certain anions
WO1991016066A1 (en) Composition and treatment with biologically active peptides and toxic cations
EP0455719A1 (en) SYNERGISTIC COMPOSITION CONTAINING A MAGAININ PEPTIDE AND A PGLa PEPTIDE
US5254537A (en) Composition and treatment with peptide combinations
KR20060039317A (ko) 아스퍼질러스 니듈란스로부터 분리한 신규 펩타이드 및이를 유효성분으로 함유하는 약학적 조성물
WO1992000090A1 (en) Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase

Legal Events

Date Code Title Description
RH Patent void